N,N'-Bis(4-aminophenyl)-1,3-xylylenediamine | 26114-58-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N,N'-Bis(4-aminophenyl)-1,3-xylylenediamine
• 英文别名: 4-N-[[3-[(4-aminoanilino)methyl]phenyl]methyl]benzene-1,4-diamine
• CAS: 26114-58-9
• 化学式: C₂₀H₂₂N₄
• 分子量: 318.4
• InChiKey: FASAHBTVMQATOS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  76.1
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• Double para-phenylenediamines joined by an aromatic group for dyeing keratin fibers
  申请人：Sabelle Stephane

  公开号：US20070011824A1

  公开（公告）日：2007-01-18

  The present disclosure relates to a family of double para-phenylenediamines joined by a linkage comprising an aromatic group and a process for the dyeing of keratin fibers. These double para-phenylenediamines of formula (I) can be used as oxidation base for the dyeing of keratin fibers. Also disclosed are methods of dyeing, methods of making, and dyeing “kits.”

  本公开涉及一种由含芳香基的连接部分连接的双对苯二胺家族，以及染色角蛋白纤维的染色工艺。公开的式(I)的双对苯二胺可以用作氧化染料基质来染色角蛋白纤维。还公开了染色方法、制备方法和染色“套件”。
• Compositions cosmétique contenant une para-phénylènediamines doubles reliées par un groupe aromatique et utilisation en coloration
  申请人：L'ORÉAL

  公开号：EP1739085A1

  公开（公告）日：2007-01-03

  La présente demande concerne une nouvelle famille de para-phénylènediamines doubles reliées par un bras de liaison comportant un groupement aromatique et leur utilisation pour la coloration des fibres kératiniques. Ces nouvelles para-phénylènediamines doubles de formule (I) sont utiles en tant que base d'oxydation pour la coloration des fibres kératiniques.

  本申请涉及一种由含有芳香族基团的连接臂连接的新型双对苯二胺系列及其在角蛋白纤维着色中的应用。 这些新的式（I）双对苯二胺可用作角蛋白纤维着色的氧化基。
• Photoalignment composition
  申请人：ROLIC AG

  公开号：US10558089B2

  公开（公告）日：2020-02-11

  The present invention relates to a photoalignment composition comprising a) 0.001 to 20%, by weight; preferably, 1 to 10% by weight, more preferably 1 to 9% by weight of at least one photoreactive compound (I) that comprises a photoalignment group and b) 80 to 99.999% by weight, preferably, 90 to 99% by weight, more preferably 91 to 99% by weight of at least one compound (II) that does not comprise a photoalignment group, and c) optionally at least one reactive or non reactive additives, and d) optionally at least one solvent. Further, the present invention relates to the use of this photoalignment composition for the alignment of liquid crystals or liquid crystal polymers, in electro-optical and optical elements, systems and devices.

  本发明涉及一种光配位组合物，该组合物包含 a) 至少一种包含光配位基团的光活性化合物(I)，其重量百分比为 0.001 至 20%；优选为 1 至 10%，更优选为 1 至 9%；以及 b) 至少一种不包含光配位基团的化合物(II)，其重量百分比为 80 至 99.999%(重量)，更优选90至99%(重量)，更优选91至99%(重量)的至少一种不包含光配位基团的化合物(II)，以及c)可选的至少一种活性或非活性添加剂，以及d)可选的至少一种溶剂。此外，本发明还涉及在电子光学和光学元件、系统和设备中将这种光配位组合物用于液晶或液晶聚合物的配位。
• COMPOUNDS FOR TREATING DISEASE, FOR ADMINISTERING, AND FOR PHARMACEUTICAL COMPOSITIONS
  申请人：Trent John O.

  公开号：US20130059852A1

  公开（公告）日：2013-03-07

  Some embodiments of this invention include methods for treating disease and methods for administering a compound of Formula (I). In some aspects of the invention, diseases can be treated by administration of compositions comprising a compound of Formula (I). Pharmaceutical compositions of some embodiments of the present invention comprise a compound of Formula (I).
• TEST STRIP USING FORMALDEHYDE OR PEROXIDE, FROM AMONG SARCOSINE METABOLITES, FOR DIAGNOSING PROSTATE CANCER, AND METHOD FOR DIAGNOSING PROSTATE CANCER USING SAME
  申请人：CSQUARE CO., LTD

  公开号：US20160222432A1

  公开（公告）日：2016-08-04

  The present invention relates to a test strip using formaldehyde or peroxide, which are sarcosine metabolites, for diagnosing prostate cancer, and a method for diagnosing prostate cancer by means of the test strip, the present invention allowing a simpler and more rapid diagnosis of prostate cancer than the conventional methods, such as using a spectrophotometer, and with respect to qualifying and quantifying sarcosine in urine, the test strip is reacted in a test urine sample, as with a conventional urinalysis test strip, so as to allow the color change to be visually checked, thereby allowing prostate cancer to be diagnosed without professional personnel and expensive equipment.